Chennai sero-survey reports 21.5% have Coronavirus Antibodies


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ Chennai sero-survey reports 21.5% have Coronavirus Antibodies
In Chennai 12405 were found seropositive

One-fifth of the Chennai's population has been exposed to SARS-CoV-2, the virus that causes Covid 19, according to the preliminary findings of the population-based sero survey in the
Chennai Corporation limits.

Of the 12,405 individuals, across 51 wards, tested for antibody against SARS-CoV-2, 2,673 people had evidence of exposure with a seroprevalence of 21.5%.

Of the 12,405 persons, only 173 had a history of contact with a Covid 19 patient.

The survey was carried out by the National Institute of Epidemiology and the field data collection for this took place between July 18-28. The test positivity rate at the end of July was around 10%.

Seroprevalence is the percentage of individuals of the population to have antibodies against SARS-Cov-2.

"Around 80% of the population is still susceptible to SARS-CoV-2 ingestion in Chennai," the sero survey report, released by the Chennai Corporation on Tuesday, stated.

However, it was found that seroprevalence varied vastly across various zones of Chennai Corporation.

For instance, 44.2% of the samples tested for the survey in Tondiarpet zone were found positive for IgG antibodies against SARS-Cov-2, which means that they have had previous exposure to the virus.

On the other hand, only 7.1% of those tested for the antibodies in the Madhavaram zone were found to have them.

Royapuram, another high-incidence zone, also recorded high seroprevalence of 34.4%. The Perungudi zone was found to have low seroprevalence of 7.3%.

"We need to understand the reasons for varying seroprevalence across zones to improve our control measures," the survey stated.

The ward-wise break up showed that Korukkpet (Ward 47), had 50% seroprevalence. New Washermanpet (Ward 39) had 49% seroprevalence while Mugalivakam (Ward 156) and Lakshmipuram (Ward 32) had the lowest seroprevalence of 2% and 3% respectively.

Meanwhile, out of the overall seroprevalence, women were found to have a higher percentage of seroprevalence (23.7%) when compared to men (19.3%). Across age groups, those between the ages of 10 and 19 had higher seroprevalence of 23.8% whereas those above the age of 60 had the lowest (15.9%).

The results also showed that the Infection to Case ratio (the number of cases of a disease compared to the number of infections with the agent that causes the disease) for the period of 14 July was 22.4%.

This, the survey said, was lower compared to some published studies, indicating high testing.

Apart from this, around 1.35 lakh people in Chennai have been tested positive for Covid 19 out of which 1.19 lakh have recovered as on Tuesday.

Addressing reporters, Chennai Corporation Commissioner G Prakash said that such seroprevalence surveys will continue.

"Wherever seroprevalence is high, reflection of (Covid 19) cases is lower. We can see that they are now stabilising in these areas- this is a natural outcome, the transmission speed will come down where
seroprevalence is high," he said.

"This was done 35 days ago, the seroprevalence will be higher now. It is important to know this because it is only then we will be able to balance interventions. We can increase interventions where seroprevalence is low," he added.

Story Source : https://www.newindianexpress.com 

Tags : #Chennai #SeropostiveChennai #Royapuram #korukkpet #NationalInstituteofEpidimiology #latestChennaiCovidNewsSep2 #GPrakash

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Tier-2 and Tier-3 Cities: India's Next Big Healthcare Growth StorySeptember 18, 2026
Why Regional Hospital Chains Are Becoming More Important in IndiaSeptember 18, 2026
The Future of Indian MedTech Exports: Can India Compete With Global Leaders?September 17, 2026
Robotic-Assisted Procedures Beyond Surgery: Where Is Automation Going Next in Healthcare?September 17, 2026
58 Students from SRM Medical College Selected for Union Government Research Programmes and Grants September 16, 2026
Handpickd Questions the Role of Science in Food with ‘Science-Less’ Newspaper CampaignSeptember 16, 2026
As Women’s Cancer Burden Rises, Integrated Care Emerges as The Next Frontier in Cancer TreatmentSeptember 16, 2026
Odia Superstar Babushaan Mohanty Inaugurates Manoj Das Library at Utkal Gaurav International SchoolSeptember 16, 2026
Yashoda Hospitals, Somajiguda Successfully Treats 10-Month-Old with Complex Heart Condition Through Staged ApproachSeptember 16, 2026
Tracky launches 16D, India's first 16-day continuous glucose monitoring system (CGM)September 16, 2026
Why Local Medical Device Manufacturing Matters for Indian HealthcareSeptember 16, 2026
Next-Generation Surgical Robots Entering the Indian Market: What It Means for Patients and ProvidersSeptember 16, 2026
ShardaCare - Healthcity Marks World Sepsis Day with Training for Over 50 NursesSeptember 15, 2026
From Empowerment to Ownership: Upasana Kamineni Konidela Calls for a BRICS Women’s Economic CorridorSeptember 15, 2026
WORLD HEART DAY 2026: Don't Miss a Beat: The Heart Attacks That Never Had to HappenSeptember 15, 2026
BL Agro Announces Investment of ₹1,500 Crore In Its Biotech-Arm Leads Genetics To Build An Integrated Dairy and Genetics EcosystemSeptember 15, 2026
Can You Have PMOS With Regular Periods? What Women Often Get WrongSeptember 15, 2026
Hospital Data Breaches in India: What Every Patient Needs to Know Right NowSeptember 15, 2026
Cybersecurity of ICUs: Protecting Connected Critical-Care Systems in Indian HospitalsSeptember 15, 2026
Fortis Hospital, Shalimar Bagh Becomes Delhi NCR’s First Multi-speciality Hospital to Launch Rezūm™ Water Vapor Therapy for Enlarged ProstateSeptember 14, 2026